Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU TopicsRespiratory

ICU · Respiratory

Non-invasive ventilation (NIV) in the ICU

Also known as NIV · BiPAP (bilevel positive airway pressure) · CPAP (continuous positive airway pressure) · Non-invasive positive pressure ventilation (NIPPV) · Pressure support via mask · Helmet CPAP

NIV delivers positive pressure ventilation via a face mask (or nasal mask/helmet) without endotracheal intubation. Reduces intubation rates, ventilator-associated pneumonia, and mortality in selected patients. CPAP: continuous positive pressure throughout respiratory cycle — splints alveoli open, reduces work of breathing, and in cardiogenic oedema reduces preload and LV afterload. BiPAP: IPAP (inspiratory positive airway pressure — pressure support) + EPAP (extrinsic PEEP). Best evidence: COPD exacerbation with type 2 respiratory failure (pH 7.25-7.35) — Plant trial 2000; cardiogenic pulmonary oedema — 3CPO 2008; immunocompromised patients with pneumonia — Hilbert 2001; and prophylactic post-extubation NIV in high-risk patients — Nava 2005. Contraindications: facial trauma, inability to protect airway (GCS <8), copious secretions, vomiting, agitation, cardiac arrest. The single most important principle: reassess at one hour — if no improvement, intubate. NIV is a time-limited trial, not an open-ended commitment.

high17 referencesUpdated 20 Aug 20269 min readVerification in progress

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • NIV is NOT a substitute for intubation in patients who cannot protect their airway
  • If no improvement within 1-2 hours of NIV: intubate (do NOT persist with NIV indefinitely)
  • Contraindications: facial trauma, decreased GCS (&lt;8), copious secretions, vomiting, agitation, cardiac arrest
  • COPD with pH &lt;7.25 despite NIV: intubate (NIV failure)
  • Do NOT use NIV as rescue therapy AFTER extubation failure — Esteban 2004 showed increased mortality; intubate instead
  • High-concentration oxygen worsens hypercapnia and acidosis in COPD — use titrated oxygen (Austin 2010)
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • NIV is NOT a substitute for intubation in patients who cannot protect their airway
  • If no improvement within 1-2 hours of NIV: intubate (do NOT persist with NIV indefinitely)
  • Contraindications: facial trauma, decreased GCS (&lt;8), copious secretions, vomiting, agitation, cardiac arrest
  • COPD with pH &lt;7.25 despite NIV: intubate (NIV failure)
  • Do NOT use NIV as rescue therapy AFTER extubation failure — Esteban 2004 showed increased mortality; intubate instead
  • High-concentration oxygen worsens hypercapnia and acidosis in COPD — use titrated oxygen (Austin 2010)
In one line

NIV delivers positive pressure via mask (no intubation). CPAP: continuous pressure (splints alveoli, reduces preload/afterload in pulmonary oedema). BiPAP: IPAP (pressure support) + EPAP (PEEP). Best evidence: COPD with type 2 RF (mild-moderate acidosis, pH 7.25-7.35) — Plant 2000; cardiogenic pulmonary oedema — 3CPO 2008; immunocompromised pneumonia — Hilbert 2001; prophylactic post-extubation in high-risk — Nava 2005. Start early — typically IPAP 10-15, EPAP 4-5 (BTS), titrated oxygen. Assess at 1-2h — if no improvement: intubate. Contraindicated: facial trauma, GCS <8, copious secretions, vomiting, agitation. The pH drives the support: pH >7.35 standard therapy; pH 7.25-7.35 NIV; pH <7.25 NIV in a monitored setting or intubate.

[1] [2] [17]

How NIV works — the physiology

NIV delivers positive pressure to the airway through a leak-tight interface, doing mechanical work the fatiguing patient can no longer do. Two pressure domains matter. [1]

EPAP / PEEP / CPAP (extrinsic, set pressure during exhalation):

  • Recruits collapsed alveoli and splints them open throughout the respiratory cycle, increasing functional residual capacity and lung compliance — less work per breath.
  • Overcomes intrinsic PEEP (auto-PEEP) in obstructed patients: by raising extrinsic pressure toward intrinsic PEEP, it lowers the pressure gradient the diaphragm must generate to trigger a breath. This is the principal mechanism by which BiPAP unloads the COPD patient.
  • Reduces preload (decreased venous return) and LV afterload (decreased transmural LV pressure) — the haemodynamic mechanism in cardiogenic pulmonary oedema.
  • Redistributes alveolar oedema out of the alveolar space (cardiogenic oedema). [1]

IPAP / pressure support (the inspiratory boost):

  • Augments every patient-triggered breath, increasing tidal volume and minute ventilation, washing out CO2.
  • The IPAP-EPAP gradient IS the pressure support: IPAP 15 / EPAP 5 = 10 cmH2O of pressure support. To increase ventilation, raise IPAP; to increase oxygenation/recruitment, raise EPAP — but raising EPAP also raises IPAP and shortens expiration, so watch for dynamic hyperinflation in COPD. [1]

Clinical translation. A COPD patient tiring against their intrinsic PEEP needs EPAP to lower the trigger threshold and IPAP to boost tidal volume and blow off CO2. A pulmonary-oedema patient needs the continuous pressure (CPAP is sufficient) to preload- and afterload-reduce and recruit. An immunocompromised patient needs the mask pressure to bridge while the underlying insult is treated, avoiding the infectious morbidity of a tube. [1]

ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References17ShowHide
  1. [1]Nava S, Hill N Non-invasive ventilation in acute respiratory failure Lancet, 2009.PMID 19616722
  2. [2]Davidson AC, Banham S, Elliott M, et al. BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults Thorax, 2016.PMID 26976648
  3. [3]Lightowler JV, Wedzicha JA, Elliott MW, et al. Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis BMJ, 2003.PMID 12543832
  4. [4]Plant PK, Owen JL, Elliott MW Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial Lancet, 2000.PMID 10859037
  5. [5]Gray A, Goodacre S, Newby DE, et al. Noninvasive ventilation in acute cardiogenic pulmonary edema N Engl J Med, 2008.PMID 18614781
  6. [6]Hilbert G, Gruson D, Vargas F, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure N Engl J Med, 2001.PMID 11172189
  7. [7]Nava S, Gregoretti C, Fanfulla F, et al. Noninvasive ventilation to prevent respiratory failure after extubation in high-risk patients Crit Care Med, 2005.PMID 16276167
  8. [8]Esteban A, Frutos-Vivar F, Ferguson ND, et al. Noninvasive positive-pressure ventilation for respiratory failure after extubation N Engl J Med, 2004.PMID 15190137
  9. [9]Patel BK, Wolfe KS, Pohlman AS, et al. Effect of Noninvasive Ventilation Delivered by Helmet vs Face Mask on the Rate of Endotracheal Intubation in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial JAMA, 2016.PMID 27179847
  10. [10]Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure N Engl J Med, 2015.PMID 25981908
  11. [11]Duan J, Han X, Bai L, et al. Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients Intensive Care Med, 2017.PMID 27812731
  12. [12]Perkins GD, Ji C, Connolly BA, et al. Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial JAMA, 2022.PMID 35072713
  13. [13]Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease N Engl J Med, 1995.PMID 7651472
  14. [14]Confalonieri M, Potena A, Carbone G, et al. Acute respiratory failure in patients with severe community-acquired pneumonia: a prospective randomized evaluation of noninvasive ventilation Am J Respir Crit Care Med, 1999.PMID 10556125
  15. [15]Austin MA, Wills KE, Blizzard L, et al. Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial BMJ, 2010.PMID 20959284
  16. [16]Ferrer M, Valencia M, Nicolas JM, et al. Early noninvasive ventilation averts extubation failure in patients at risk: a randomized controlled trial Am J Respir Crit Care Med, 2006.PMID 16224108
  17. [17]Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure Eur Respir J, 2017.PMID 28860265

Test yourself

Practise what you just read

  • 8 MCQs
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousMechanical ventilation: modes, settings, troubleshooting, and weaningRespiratoryNextOxygen therapy and high-flow nasal cannula in acute respiratory failureRespiratory